Literature DB >> 10992501

Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate.

K E Veldkamp1, H C Heezius, J Verhoef, J A van Strijp, K P van Kessel.   

Abstract

In a previous study, we showed that Staphylococcus aureus supernate (SaS) is a potent agonist for both neutrophils and mononuclear cells. To further investigate the immunomodulating effects of SaS, the effect on different neutrophil receptors was studied. Expression of various neutrophil receptors, before and after treatment with SaS, was quantified by flow cytometry. We found that SaS treatment of neutrophils resulted in a specific and total downregulation of the C5a and the fMLP receptor, both serpentine receptors, while other receptors were totally unaffected. Since these two receptors are both involved in chemotaxis, we tested the effect of SaS in calcium flux and chemotaxis assays. We showed that preincubation with SaS abrogated the rise in intracellular calcium concentration upon triggering with fMLP and C5a. We also showed that SaS is a potent inhibitor of neutrophil chemotaxis towards fMLP and C5a, but does not interfere with chemotaxis towards interleukin-8. These findings indicate that S. aureus produces a virulence factor extracellularly, which impairs chemotaxis towards the infected site.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992501      PMCID: PMC101553          DOI: 10.1128/IAI.68.10.5908-5913.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMet-Leu-Phe or C5a.

Authors:  U Wirthmueller; M Baggiolini; A L de Weck; C A Dahinden
Journal:  Biochem Biophys Res Commun       Date:  1991-05-15       Impact factor: 3.575

2.  [Inhibition of leukocyte migration in vitro by a capsular polyoside of Torulopsis (Cryptococcus) neoformans].

Authors:  E DROUHET; G SEGRETAIN
Journal:  Ann Inst Pasteur (Paris)       Date:  1951-12

3.  Effect of protein A on staphylococcal opsonization.

Authors:  P K Peterson; J Verhoef; L D Sabath; P G Quie
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

4.  Group B streptococci inhibit the chemotactic activity of the fifth component of complement.

Authors:  H R Hill; J F Bohnsack; E Z Morris; N H Augustine; C J Parker; P P Cleary; J T Wu
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

Review 5.  Roles of G protein subunits in transmembrane signalling.

Authors:  E J Neer; D E Clapham
Journal:  Nature       Date:  1988-05-12       Impact factor: 49.962

6.  Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein.

Authors:  T Katada; M Ui
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

Review 7.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

8.  Stimulation of monokine production by lipoteichoic acids.

Authors:  S Bhakdi; T Klonisch; P Nuber; W Fischer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

9.  Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species.

Authors:  J F Bohnsack; J K Chang; H R Hill
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

10.  Staphylococcus aureus tetrapeptide with high chemotactic potency and efficacy for human leukocytes.

Authors:  A Rot; L E Henderson; R Sowder; E J Leonard
Journal:  J Leukoc Biol       Date:  1989-02       Impact factor: 4.962

View more
  19 in total

1.  40 years of methicillin resistant Staphylococcus aureus.

Authors:  A van Belkum; H Verbrugh
Journal:  BMJ       Date:  2001-09-22

Review 2.  Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense.

Authors:  Manuela Dürr; Andreas Peschel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 3.  Bacteriophage control of bacterial virulence.

Authors:  Patrick L Wagner; Matthew K Waldor
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

4.  Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo.

Authors:  Devipriya Subramaniyam; Chad Steele; Thomas Köhnlein; Tobias Welte; Olof Grip; Sadis Matalon; Sabina Janciauskiene
Journal:  Inflamm Res       Date:  2010-03-18       Impact factor: 4.575

5.  Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity.

Authors:  Greg A Somerville; Alan Cockayne; Manuela Dürr; Andreas Peschel; Michael Otto; James M Musser
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

Review 6.  The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes.

Authors:  S Anwar; L R Prince; S J Foster; M K B Whyte; I Sabroe
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

7.  Human neutrophil chemotaxis is modulated by capsule and O antigen from an extraintestinal pathogenic Escherichia coli strain.

Authors:  Thomas A Russo; Bruce A Davidson; Diana M Topolnycky; Ruth Olson; Stacy A Morrill; Paul R Knight; Philip M Murphy
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Alpha-defensin 1 (human neutrophil protein 1) as an antichemotactic agent for human polymorphonuclear leukocytes.

Authors:  P S Grutkoski; C T Graeber; Y P Lim; A Ayala; H H Simms
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy.

Authors:  Huamei Fu; Claes Dahlgren; Johan Bylund
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

10.  Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus.

Authors:  D P Crosara-Alberto; A L C Darini; R Y Inoue; J S Silva; S H Ferreira; F Q Cunha
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.